PATENT CLAIM ANALYSIS

Application Number: 16124648
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["424", "190100"]

Abstract:
The present invention provides antigenic polypeptides expressed during an infection by a pathogenic organism, such as  Acinetobacter  and compositions comprising these polypeptides. The invention further provides compositions for use in treating, preventing or detecting a bacterial infection, in particular vaccine compositions using the antigenic polypeptides. The invention further provides antibodies directed to said antigenic polypeptides.

Claim (Index 42):
The antibody of  claim 36 , in a eukaryotic expression host cell adapted to express the antibody.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 97.0
- Lexical Diversity: 1.525
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14362058', '15427976', '15896791', '15896761', '15897458']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7215533929561987
- 35 USC 102 Novelty (BERT): 0.5115647504822727
- Combined Prediction Score: 0.7005545287088061
- Mean Citation Score: 264.454656
- Max Citation Score: 276.61954
- Similarity Product: 215.0439361121106

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test